Cushing’s syndrome in a clinic population with diabetes
Abstract
BACKGROUND: A recent report has suggested that occult Cushing's syndrome (CS) may be present in a significant number of patients with type 2 diabetes mellitus. The aim of this study was to determine whether any patients in our clinic population with diabetes had this condition. METHODS: One hundred and seventy-one consecutive overweight attendees at the diabetic clinic were enrolled in a study to assess the presence of occult CS. The initial screen was with the 1 mg overnight dexamethasone suppression test and follow-up testing, where indicated was with a 24 h collection for urine-free cortisol. RESULTS: Thirty-one of 171 patients had a positive result from the overnight dexamethasone suppression test. Follow-up testing with 24 h urine-free cortisol reduced the number of patients with positive results to 3. Two of these were shown to have alcoholic pseudo-CS. The third patient has had several high urine-free cortisol results, in the presence of normal scans of pituitary and adrenals. He has no stigmata of CS and is being observed. CONCLUSION: Based on the results of our study, there would appear to be little value in screening type 2 diabetics for CS, in the absence of clinical suspicion.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The prevalence of previously unsuspected Cushing syndrome in patients with type 2 diabetes ranges from 0% to 9.4%.
“The association between DM and CS has been examined in various studies, which have shown a prevalence of previously unsuspected CS in patients with type DM ranging from % to .% (Table ) (-).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [252]
Newsome et al. found no subclinical hypercortisolism in 178 diabetic patients using a low-cutoff 1-mg dexamethasone suppression test.
“By using 1-mg DST as a screening test with a low cutoff in a sample of 178 diabetic patients, Newsome et al. (86) did not find any subject with SH.”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [86]
Cites
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777 · see citing works
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362 · see citing works
Newell-Price, J. D. C., BERTAGNA, X. Y., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,220 · see citing works
The Diagnosis and Differential Diagnosis of Cushing’s Syndrome and Pseudo-Cushing’s States
Newell-Price, J., Trainer, P., Besser, M., & Grossman, A. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.5.0346 · Cited by 833 · see citing works
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622 · see citing works
Use of Sildenafil (Viagra) in Patients With Cardiovascular Disease
Cheitlin, M. D., Hutter, A. M., Brindis, R. G., Ganz, P., Kaul, S., Russell, R. O., Zusman, R. M., Forrester, J. S., Douglas, P. S., Faxon, D. P., et al. (1999) · Circulation · doi:10.1161/01.cir.99.1.168 · Cited by 497 · see citing works
Rossi, R., Tauchmanovà, L., Luciano, A., Martino, M. D., Battista, C., Viscovo, L. D., Nuzzo, V., & Lombardi, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6515 · Cited by 416 · see citing works
Cushing's syndrome: a review of diagnostic tests.
Crapo, L. (1979) · Metabolism · doi:10.1016/0026-0495(79)90097-0 · Cited by 393 · see citing works
The Diagnosis and Differential Diagnosis of Cushing's Syndrome and Pseudo-Cushing's States
Newell-Price, J. D. C. (1998) · Endocrine Reviews · doi:10.1210/er.19.5.647 · Cited by 360 · see citing works
Occult Cushing’s syndrome in type-2 diabetes
Catargi, B., Rigalleau, V., Poussin, A., Ronci-Chaix, N., Bex, V., Vergnot, V., Gin, H., Roger, P., & Tabarin, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030254 · Cited by 287 · see citing works
Atkinson, A., Kennedy, A., Wiggam, M., McCance, D., & Sheridan, B. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02380.x · Cited by 265 · see citing works
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
Farrell, G. C. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02989.x · Cited by 235 · see citing works
A single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome
Newell-Price, J. D. C., Trainer, P. J., Perry, L., Wass, J. A. H., Grossman, A. B., & Besser, M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02918.x · Cited by 221 · see citing works
Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo, Osella, Alì, Borretta, Cesario, Paccotti, & Angeli, A. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00357.x · Cited by 198 · see citing works
Late-night salivary cortisol as a screening test for cushing's syndrome
Raff, H. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2681 · Cited by 194 · see citing works
Wood, P. J., Barth, J. H., Freedman, D. B., Perry, L., & Sheridan, B. (1997) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456329703400302 · Cited by 190 · see citing works
Leibowitz, G., Tsur, A., Chayen, S. D., Salameh, M., Raz, I., Cerasi, E., & Gross, D. J. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.737558.x · Cited by 180 · see citing works
Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans.
Liu, H., Bravata, D. M., Cabaccan, J., Raff, H., & Ryzen, E. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02395.x · Cited by 178 · see citing works
Development of overt Cushing’s syndrome in patients with adrenal incidentaloma
Barzon, L., Fallo, F., Sonino, N., & Boscaro, M. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460061 · Cited by 162 · see citing works
Five cases of cyclical Cushing's syndrome.
Atkinson, A. B., Kennedy, A., Carson, D. J., Hadden, D. R., Weaver, J. A., & Sheridan, B. (1985) · BMJ · doi:10.1136/bmj.291.6507.1453 · Cited by 127 · see citing works
THE OVERNIGHT DEXAMETHASONE TEST IS A WORTHWHILE SCREENING PROCEDURE
Cronin, C. M. G., Igoe, D., Duffy, M. J., Cunningham, S. K., & McKenna, T. J. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00462.x · Cited by 93 · see citing works
The Effects of Alcohol on the Endocrine System
Noth, R. H., & WaIter, R. M. (1984) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31246-9 · Cited by 90 · see citing works
The Diagnosis of Cushing's Syndrome
Boscaro, M., Barzon, L., & Sonino, N. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.20.3045 · Cited by 84 · see citing works
The Role of P-Glycoprotein and Organic Anion-Transporting Polypeptides in Drug Interactions
DuBuske, L. M. (2005) · Drug Safety · doi:10.2165/00002018-200528090-00004 · Cited by 84 · see citing works
McWhinney, B. C., Ward, G., & Hickman, P. E. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.6.979 · Cited by 54 · see citing works
Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy.
Kyriazopoulou, V. E., & Vagenakis, A. G. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.1.1619024 · Cited by 40 · see citing works
Overnight dexamethasone suppression test: normal responses and the diagnosis of cushing's syndrome
Blethen, S. L., & Chasalow, F. I. (1989) · Steroids · doi:10.1016/0039-128x(89)90093-7 · Cited by 36 · see citing works
Zoppini, G., Targher, G., Venturi, C., Zamboni, C., & Muggeo, M. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02154.x · Cited by 30 · see citing works
Fok, A. C. K., Tan, K. T., Jacob, E., & Sum, C. F. (1991) · Steroids · doi:10.1016/0039-128x(91)90011-j · Cited by 15 · see citing works
Mattingly, D., Martin, H., & Tyler, C. J. (1989) · Journal of Clinical Pathology · doi:10.1136/jcp.42.6.661 · Cited by 14 · see citing works
Abnormal overnight dexamethasone suppression test in subjects receiving rifampicin therapy
Kyriazopoulou, V. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.1.315 · Cited by 14 · see citing works
Kaye, T., Rubin, R. A., Goldfine, A. B., Rajamani, K. K., Kinsley, B., Vischer, U. M., & Simonson, D. C. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.3.1740499 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777 · see citing works
Diagnosis and Treatment of Subclinical Hypercortisolism
Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279 · see citing works
Increased salt consumption induces body water conservation and decreases fluid intake
Rakova, N., Kitada, K., Lerchl, K., Dahlmann, A., Birukov, A., Daub, S., Kopp, C., Pedchenko, T., Zhang, Y., Beck, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88530 · Cited by 157 · see citing works
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140 · see citing works
Findling, J. W., & Raff, H. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0946 · Cited by 134 · see citing works
Cushing's syndrome: epidemiology and developments in disease management
Feelders, R., Sharma, S., & Nieman, L. (2015) · Clinical Epidemiology · doi:10.2147/clep.s44336 · Cited by 210 · see citing works
Terzolo, M., Reimondo, G., Chiodini, I., Castello, R., Giordano, R., Ciccarelli, E., Limone, P., Crivellaro, C., Martinelli, I., Montini, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1323 · Cited by 89 · see citing works
Fierabracci, P., Pinchera, A., Martinelli, S., Scartabelli, G., Salvetti, G., Giannetti, M., Pucci, A. B. F., Galli, G., Ricco, I., Querci, G., et al. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0297-6 · Cited by 73 · see citing works
Cushing’s syndrome: diagnosis and surveillance using salivary cortisol
Raff, H. (2011) · Pituitary · doi:10.1007/s11102-011-0333-0 · Cited by 70 · see citing works
Is there value in routine screening for Cushing’s syndrome in patients with diabetes?
Mullan, K., Black, N., Thiraviaraj, A., Bell, P. M., Burgess, C., Hunter, S. J., McCance, D. R., Leslie, H., Sheridan, B., & Atkinson, A. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2453 · Cited by 65 · see citing works
Glucose metabolism in patients with subclinical Cushing’s syndrome
Giordano, R., Guaraldi, F., Berardelli, R., Karamouzis, I., D’Angelo, V., Marinazzo, E., Picu, A., Ghigo, E., & Arvat, E. (2012) · Endocrine · doi:10.1007/s12020-012-9628-9 · Cited by 63 · see citing works
Martins, L. C., Conceição, F. L., Muxfeldt, E. S., & Salles, G. F. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283521484 · Cited by 61 · see citing works
Pros and cons of screening for occult Cushing syndrome
Tabarin, A., & Perez, P. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.51 · Cited by 57 · see citing works
Tissue sodium accumulation and peripheral insulin sensitivity in maintenance hemodialysis patients
Değer, S. M., Wang, P., Fissell, R. B., Ellis, C. D., Booker, C., Sha, F., Morse, J. L., Stewart, T. G., Gore, J. C., Siew, E. D., et al. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12179 · Cited by 36 · see citing works
Do patients with type 2 diabetes mellitus have an increased prevalence of Cushing’s syndrome?
Krarup, T., Krarup, T., & Hagen, C. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2262 · Cited by 30 · see citing works
Hidden hypercortisolism: a too frequently neglected clinical condition
Giovanelli, L., Aresta, C., Favero, V., Bonomi, M., Cangiano, B., Eller-Vainicher, C., Grassi, G., Morelli, V., Pugliese, F., Falchetti, A., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01484-2 · Cited by 32 · see citing works
Steffensen, C., Pereira, A. M., Dekkers, O. M., & Jørgensen, J. O. L. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0434 · Cited by 32 · see citing works
When to Suspect Hidden Hypercortisolism in Type 2 Diabetes: A Meta-Analysis
Aresta, C., Soranna, D., Giovanelli, L., Favero, V., Parazzoli, C., Gennari, L., Persani, L., Scillitani, A., Blevins, L. S., Brown, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.07.014 · Cited by 28 · see citing works
Steffensen, C., Dekkers, O. M., Lyhne, J. D., Pedersen, B. G., Rasmussen, F., Rungby, J., Poulsen, P. L., & Jørgensen, J. O. L. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0809-3647 · Cited by 24 · see citing works
Cushing′s syndrome: Stepwise approach to diagnosis
Lila, A. R., Sarathi, V., Jagtap, V., Bandgar, T., Menon, P. S. N., & Shah, N. (2011) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.86974 · Cited by 23 · see citing works
Machado, M. C., Fragoso, M. C. B. V., Moreira, A. C., Boguszewski, C. L., Vieira Neto, L., Naves, L. A., Vilar, L., Araújo, L. A. D., Czepielewski, M. A., Gadelha, M. R., et al. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000174 · Cited by 21 · see citing works
Bellastella, G., Maiorino, M. I., Bellis, A. D., Vietri, M. T., Mosca, C., Scappaticcio, L., Pasquali, D., Esposito, K., & Giugliano, D. (2015) · Endocrine · doi:10.1007/s12020-015-0777-5 · Cited by 22 · see citing works
Costa, D., Conceição, F. L., Leite, N. C., Ferreira, M. T., Salles, G. F., & Cardoso, C. R. L. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.05.006 · Cited by 22 · see citing works
Cushing’s syndrome in type 2 diabetes patients with poor glycemic control
Güngüneş, A., Şahi̇n, M., Demirci, T., Uçan, B., Çakır, E., Arslan, M. S., Ünsal, İ. Ö., Karbek, B., Çalışkan, M., Özbek, M., et al. (2014) · Endocrine · doi:10.1007/s12020-014-0260-8 · Cited by 21 · see citing works
Cushing’s syndrome: Why is diagnosis so difficult?
Aron, D. C. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9127-3 · Cited by 20 · see citing works
Budyal, S., Jadhav, S. S., Kasaliwal, R., Patt, H., Khare, S., Shivane, V., Lila, A. R., Bandgar, T., & Shah, N. S. (2015) · Endocrine Connections · doi:10.1530/ec-15-0078 · Cited by 19 · see citing works
Which type 2 diabetes mellitus patients should be screened for subclinical Cushing’s syndrome?
Cansu, G. B., Atılgan, S., Balcı, M. K., Sarı, R., Özdem, S., & Altunbaş, H. (2017) · HORMONES · doi:10.14310/horm.2002.1716 · Cited by 17 · see citing works
Stachowska, B., Kuliczkowska-Płaksej, J., Kałużny, M., Grzegrzółka, J., Jończyk, M., & Bolanowski, M. (2020) · Endocrine · doi:10.1007/s12020-020-02468-1 · Cited by 13 · see citing works
Incidence of Cushing’s syndrome in patients with significant hypercortisoluria
Hirsch, D., Tsvetov, G., Manisterski, Y., Aviran-Barak, N., Nadler, V., Alboim, S., & Kopel, V. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0631 · Cited by 13 · see citing works
Relationship between type 2 diabetes mellitus and hypothalamic-pituitary-adrenal axis
Felšöci, M., Schroner, Z., Petrovičová, J., & Lazúrová, I. (2010) · Wiener klinische Wochenschrift · doi:10.1007/s00508-010-1497-8 · Cited by 13 · see citing works
Olędzka, I., Plenis, A., Konieczna, L., Kowalski, P., & Bączek, T. (2010) · Electrophoresis · doi:10.1002/elps.201000144 · Cited by 13 · see citing works
Routine screening for Cushing's syndrome is not required in patients presenting with hirsutism
Karaca, Z., Açmaz, B., Açmaz, G., Tanrıverdi, F., Unluhizarci, K., Aribaş, S., Sahin, Y., & Keleştimur, F. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0938 · Cited by 13 · see citing works
Update on the risks of benign adrenocortical incidentalomas
Dalmazi, G. D. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000341 · Cited by 9 · see citing works
Who and how to screen for endogenous hypercortisolism in type 2 diabetes mellitus or obesity
Guarnotta, V., Giordano, C. S. D. S., & Reimondo, G. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02455-7 · Cited by 7 · see citing works
Incidentally discovered pituitary masses: pituitary incidentalomas
Abdelmannan, D. K., & Aron, D. C. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.68 · Cited by 6 · see citing works
Barrea, L., Caprio, M., Perrini, S., Camajani, E., Crafa, A., Gangitano, E., Gorini, S., Sciacca, L., Verde, L., Albertelli, M., et al. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02589-2 · Cited by 4 · see citing works
Findling, J. W., & Raff, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_6 · Cited by 4 · see citing works
Juszczak, A., Morris, D. G., Grossman, A. B., & Nieman, L. K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00013-5 · Cited by 4 · see citing works
Cushing Syndrome—Unilateral Adrenal Adenoma
Dalmazi, G. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65213-3 · Cited by 1 · see citing works
Hewapathirana, N. M., & Page, S. (2010) · The British Journal of Diabetes · doi:10.1177/1474651410374193
Hipercortisolismo de origen suprarrenal: síndrome de Cushing
Blasco, F. Á., Buesa, M. A., Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2012) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(12)70398-0
Cushing’s syndrome in obese patients with type 2 diabetes: A single center screening study
Karaman, Ö., Zuhur, S. S., Çil, E., Özderya, A., Öztürk, F. Y., İlhan, M., & Altuntaş, Y. (2016) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-016-0494-5
Karuppiah, D., Cooray, M., Somasundaram, N. P., & Ediriweera, D. (2018) · International Journal of Advanced Research · doi:10.21474/ijar01/6262
Morris, D. G., Grossman, A. B., & Nieman, L. K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00015-0
Baudry, C., Waintrop, C., & Mosnier-Pudar, H. (2011) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(11)53860-0
Is It Relevant to Screen Subclinical Cushing’s Syndrome in Patients With Type 2 Diabetes Mellitus?
Hadiji, M. J., Ksira, I., Haouat, E., Jamoussi, H. K., & Hachmi, L. B. S. (2017) · Journal of Endocrinology and Metabolism · doi:10.14740/jem454w
Cushing syndrome—Unilateral adrenal adenoma
Dalmazi, G. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00221-1
- Authors
- Newsome, S., Chen, K., Hoang, J., Wilson, J. D., Potter, J. M., & Hickman, P. E.
- Affiliations
- Australian National University (AU)
- Corresponding author
- Hickman, P. E.
- Venue
- Internal Medicine Journal
- Publisher
- Wiley
- Published
- 2007-07-23
- Volume
- 38
- Issue
- 3
- Pages
- 178-182
- ISSN
- 1444-0903 (ISSN-L)
- 1445-5994
- OpenAlex
- W2033709422
- Cited by
- 48
- References
- 31
- Citations by year
- 2025: 2 · 2024: 1 · 2021: 2 · 2020: 1 · 2018: 3 · 2017: 7 · 2016: 6 · 2015: 6 · 2014: 1 · 2012: 5
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Internal Medicine Journal (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Electrolyte and hormonal disorders
- Keywords
- Cushing's syndrome, type 2 diabetes, dexamethasone suppression test, 24-hour urine free cortisol, screening, overweight patients
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Cushing Syndrome, Dexamethasone, Diabetes Mellitus, Type 2, Female, Humans, Hydrocortisone, Male, Middle Aged, Prospective Studies, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review